Collexis Launches Community Feature for Academic Customers

Connecting Experts From Over 16 Institutions Through Expert Profiling

AMSTERDAM, July 13, 2010 - Elsevier, a world-leading publisher of scientific, technical and medical
information products and services, today announced that Collexis, an Elsevier
business and leading developer of semantic technology and knowledge discovery
software, has launched its community module for their Expert Profiling
application. The release of version 3.6 Expert Profiling connects experts
across the Collexis community from multiple institutions by research
concepts.

"We are very excited about latest release of Expert Profiling as this not
only helps researchers connect across disciplines but also across member
institutions," noted Jay Katzen, Managing Director, Elsevier Science and
Technology. "This transparency across institutions can lead to new
collaborations that will enhance the research process and the quest for new
cures to the most challenging diseases."

"Over the past few years, the NIH has focused on increasing networking
and collaboration through CTSA awards and the VIVO initiative. The Collexis
Expert Profiling community module also supports these goals as well as
provide interoperability between VIVO and the Collexis application," stated
Christian Herzog, MD, Managing Director Collexis. "Prior to the acquisition
by Elsevier the Collexis profiles were based on PubMed data, now the profiles
will be powered by the 18,000 peer review journals within Scopus which will
not only strengthen the life science profiles but allow us to provide expert
profiles in all scientific disciplines!"

The Collexis Expert Profiling community module allows for the
identification of not only an institution's research experts based on their
historical publications but research experts from other institutions who
subscribe to the Collexis Expert Profiling application. Additional features
within the Collexis Expert Profiling application include the capability of
finding similar experts, searching by key concept and provide the "Scientific
Context"; that will display related experts, grants and publications based on
the Fingerprint of an individual grant or publication.

The following institutions comprise the current Collexis community;
Albert Einstein College of Medicine (
www.researchprofiles.collexis.com/einstein/), Johns Hopkins
University, University of Maryland, Medical College of Georgia, University of
Miami, University of Michigan Medical School, Memorial Sloan-Kettering Cancer
Center, Oregon Health & Science University, University of California, Davis,
The University of Texas Health Science Center at San Antonio and Wayne State
University.

About Collexis - An Elsevier Business

Collexis, a leading developer of semantic technology and knowledge
discovery software based in New York, NY (USA) with operations in Cologne,
Germany and Valparaiso, Chile. Collexis now offers the world's first
pre-populated scientific social network for life science researchers,
www.biomedexperts.com. Collexis' proprietary technology builds
conceptual profiles of text, called Fingerprints, from documents, Websites,
emails and other digitized content and matches them with a comprehensive list
of pre-defined "fingerprinted" concepts to make research results more
relevant and efficient. This matching of concepts eliminates the ambiguity
and lack of priority associated with word searches. The results are often
described as "finding needles in many haystacks." Through this novel
approach, Collexis can build unique applications to search, index and
aggregate information as well as prioritize, trend and predict data based on
sources in multiple industries without the limitations of language or
dialect. Collexis' current clients in the public, private and academic
sectors include Johns Hopkins University; University of Michigan, tDavis ;
Albert Einstein College of Medicine, University of Michigan Medical School,
Memorial Sloan-Kettering Cancer Center, Oregon Health & Science University,
Lockheed Martin; the World Health Organization; Wellcome Trust; the National
Institutes of Health; and the U.S. Department of Defense.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical
information products and services. The company works in partnership with the
global science and health communities to publish more than 2,000 journals,
including The Lancet (www.thelancet.com) and Cell (www.cell.com
), and close to 20,000 book titles, including major reference works from
Mosby and Saunders. Elsevier's online solutions include ScienceDirect
(www.sciencedirect.com), Scopus (www.scopus.com), the SciVal
suite (www.scival.com), Reaxys (www.reaxys.com), MD Consult
(www.mdconsult.com) and Nursing Consult (www.nursingconsult.com
), which enhance the productivity of science and health professionals, and
MEDai's Pinpoint Review (www.medai.com), which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (
www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Media Contact
    Jen Saunders/Sandra Plasse
    Padilla Speer Beardsley
    Tel: +1-212-752-8338
    jsaunders@psbpr.com
    splasse@psbpr.com

Media Contact Jen Saunders/Sandra Plasse, Padilla Speer Beardsley, Tel: +1-212-752-8338, jsaunders at psbpr.com, splasse at psbpr.com